Athersys (ATHX), Chugai Enter License Agreement for MultiStem Development in Japan
Tweet Send to a Friend
Athersys, Inc. (Nasdaq: ATHX) and Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange:4519) have announced a partnership and license agreement to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
